These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30033373)

  • 1. The Q359K/T360K mutation causes cystic fibrosis in Georgian Jews.
    Mei-Zahav M; Stafler P; Senderowitz H; Bentur L; Livnat G; Shteinberg M; Orenstein N; Bazak L; Prais D; Levine H; Gur M; Khazanov N; Simhaev L; Eliyahu H; Cohen M; Wilschanski M; Blau H; Mussaffi H
    J Cyst Fibros; 2018 Sep; 17(5):e41-e45. PubMed ID: 30033373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
    Quint A; Lerer I; Sagi M; Abeliovich D
    Am J Med Genet A; 2005 Jul; 136(3):246-8. PubMed ID: 15948195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.
    Sereth H; Shoshani T; Bashan N; Kerem BS
    Hum Genet; 1993 Oct; 92(3):289-95. PubMed ID: 7691712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cystic fibrosis mutations in Israeli Jews.
    Orgad S; Neumann S; Loewenthal R; Netanelov-Shapira I; Gazit E
    Genet Test; 2001; 5(1):47-52. PubMed ID: 11336401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
    Mussaffi H; Prais D; Mei-Zahav M; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic risk factors for cystic fibrosis-related liver disease.
    Wilschanski M; Rivlin J; Cohen S; Augarten A; Blau H; Aviram M; Bentur L; Springer C; Vila Y; Branski D; Kerem B; Kerem E
    Pediatrics; 1999 Jan; 103(1):52-7. PubMed ID: 9917439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis in Jews: frequency and mutation distribution.
    Kerem B; Chiba-Falek O; Kerem E
    Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.
    Terlizzi V; Di Lullo AM; Comegna M; Centrone C; Pelo E; Castaldo G; Raia V; Braggion C
    Ital J Pediatr; 2018 Jan; 44(1):2. PubMed ID: 29298718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
    Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
    Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
    Ramalho AS; Fürstová E; Vonk AM; Ferrante M; Verfaillie C; Dupont L; Boon M; Proesmans M; Beekman JM; Sarouk I; Vazquez Cordero C; Vermeulen F; De Boeck K;
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32747394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews.
    Shoshani T; Berkun Y; Yahav Y; Augarten A; Bashan N; Rivlin Y; Gazit E; Sereth H; Kerem E; Kerem BS
    Genomics; 1993 Jan; 15(1):236-7. PubMed ID: 7679367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.